Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer. - Wikidata - wikimedia - TriplyDB

Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer.

Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer.

http://www.wikidata.org/entity/Q33389018

about

Perspectives in the treatment of pancreatic adenocarcinoma Recent treatment advances and novel therapies in pancreas cancer: a review.Transcriptome and proteome analysis of tyrosine kinase inhibitor treated canine mast cell tumour cells identifies potentially kit signaling-dependent genes Repositioning of Tyrosine Kinase Inhibitors as Antagonists of ATP-Binding Cassette Transporters in Anticancer Drug Resistance A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer.Antiproliferative effects of masitinib and imatinib against canine oral fibrosarcoma in vitro Autoimmune-like hepatitis during masitinib therapy in an amyotrophic lateral sclerosis patient.Phase II clinical trials on investigational drugs for the treatment of pancreatic cancers The Association Between Chemoradiation-related Lymphopenia and Clinical Outcomes in Patients With Locally Advanced Pancreatic Adenocarcinoma.Investigational therapies up to Phase II which target PDGF receptors: potential anti-cancer therapeutics.Masitinib for the treatment of mild to moderate Alzheimer's disease.Masitinib antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance.Preclinical Rationale for the Phase III Trials in Metastatic Pancreatic Cancer: Is Wishful Thinking Clouding Successful Drug Development for Pancreatic Cancer?Therapeutic Strategies Under Development Targeting Inflammatory Mechanisms in Amyotrophic Lateral Sclerosis.In vitro effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine hemangiosarcoma cell lines.Masitinib demonstrates anti-proliferative and pro-apoptotic activity in primary and metastatic feline injection-site sarcoma cells.Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer.Intraoperative Pancreatic Cancer Detection using Tumor-Specific Multimodality Molecular Imaging.Cyclooxygenase inhibitors potentiate receptor tyrosine kinase therapies in bladder cancer cells in vitro.Mast Cell, the Neglected Member of the Tumor Microenvironment: Role in Breast Cancer.

P2860

Q26797248-D0367A96-D3F1-477C-898A-AA01E5FEDE3B Q33625168-0BFB2D61-FFAA-48DB-825F-3E1F661CC416 Q34322014-EAE8245C-B288-46A8-8493-8B52B1B603DD Q34774854-3EBD453A-8B5B-4253-BA7D-2C43083C312E Q35892017-6F7FA2E2-D333-40FF-AB54-1E978DAD9B4F Q36040399-5307CF33-C195-4148-AFCF-7B989B177CC0 Q36085618-6C8EED50-2021-4706-A329-8C44B2D56418 Q36384541-FBB1C11F-2409-4B8B-B83A-80EBEE396627 Q37710295-A86BFD9F-26B0-4EE1-9773-7558984FEECA Q38323440-9FA702B7-CC4D-4C87-8556-D3FCC33D5EF5 Q38472067-C0310378-7050-4AE5-AAB2-DA0DA94968E6 Q39015818-281DAD82-E961-40AC-A37B-21A2C9C00235 Q39022032-E207E9AF-A925-46B7-88B2-DB8F21E494AF Q39271545-CA5CFF07-3737-49CD-A6B0-8F9C5470E0B4 Q39346782-CC170020-F3CC-4266-A949-F48CF7E19469 Q39413860-6B828E3D-ACAF-48D7-B33E-290686AA59BC Q45857609-371B5BF7-7347-4CED-8BE4-6ECF08476588 Q52581499-8CC3A97B-24EF-4ADC-9198-BB0B61200155 Q55254546-AD561FE4-CB74-4A17-BD0D-DC1DEE6E7E13 Q55483878-B43C402D-4DB4-422D-857F-CFAA6B9C419F

P2860

Safety and activity of masitinib in combination with gemcitabine in patients with advanced pancreatic cancer.

http://www.wikidata.org/entity/Q33389018

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Safety and activity of masitin ...... th advanced pancreatic cancer.

@ast

Safety and activity of masitin ...... th advanced pancreatic cancer.

@en

type

label

Safety and activity of masitin ...... th advanced pancreatic cancer.

@ast

Safety and activity of masitin ...... th advanced pancreatic cancer.

@en

prefLabel

Safety and activity of masitin ...... th advanced pancreatic cancer.

@ast

Safety and activity of masitin ...... th advanced pancreatic cancer.

@en

P1433

Q33389018-71580977-E3BD-4B97-A2D9-C9A02CBA64B2

P1476

Q33389018-C24B4F35-71B9-4770-9D4B-4AE4B610A8D3

P2093

Q33389018-30250508-0CDA-49DF-B73C-A8AE5A5CFE29

Q33389018-423EAC2F-3194-4022-999F-EECEE72B5AFA

Q33389018-4C60BCA2-6CAF-41B0-AC81-3F6991DEC35B

Q33389018-926CF676-FE5B-479D-AB51-8447A3B6998C

Q33389018-940087F8-5EB2-4D95-BE8F-6FAA774DF6B0

Q33389018-B9F057D0-89C3-4ECF-8603-3A991469CA54

Q33389018-E4E4C69B-9E1A-495F-B42D-2C1486EA9CFB

Q33389018-E955F43F-651E-4A18-8501-4443A098FA7B

Q33389018-FF36640D-5D6D-45C6-A2D5-86F086A13343

P2860

Q33389018-E265723E-8162-4300-8EAF-93B0517B9B27

Q33389018-F844D4C5-FBA3-469C-97DD-66ACF2FBB745

P2888

Q33389018-E8A51325-4D6A-40C8-92FD-343F4CB96F31

P304

Q33389018-FA42F4FA-E142-4E78-9A02-4E3183E710E4

P31

Q33389018-E8FD1416-8A8B-4B90-B830-5995C19F8D0E

P356

Q33389018-60DF0152-4E94-418F-A5EF-B1994A35A593

P433

Q33389018-944AFBAA-0CA7-4C5A-8930-A008F6CA52FD

P478

Q33389018-83DB2ADD-76C9-4991-9883-C84535BB8BD6

P50

Q33389018-9E825B74-2407-45DB-98AE-1713DE92F281

Q33389018-D7B93768-667A-4823-8C36-8AC705865F7D

P577

Q33389018-EB24476E-C83C-4215-ACAC-654BF1371670

P5875

Q33389018-790C5B3D-13A1-4BBD-94A1-EBAACEBE7835

P6179

Q33389018-A6E91B71-80CE-4228-AD70-A605D98647DE

P698

Q33389018-8D9D5F00-8232-4A68-89DC-B7FF7C945CD3

P356

S00280-010-1299-8

P1433

Cancer Chemotherapy and Pharmacology

P1476

Safety and activity of masitin ...... th advanced pancreatic cancer.

@en

P2093

Alain Moussy

http://www.w3.org/2001/XMLSchema#string

Emmanuel Mitry

http://www.w3.org/2001/XMLSchema#string

Eric Raymond

http://www.w3.org/2001/XMLSchema#string

Françoise Mornex

http://www.w3.org/2001/XMLSchema#string

Gaël Deplanque

http://www.w3.org/2001/XMLSchema#string

Jean-François Seitz

http://www.w3.org/2001/XMLSchema#string

Jean-Pierre Kinet

http://www.w3.org/2001/XMLSchema#string

Philippe Levy

http://www.w3.org/2001/XMLSchema#string

Philippe Rougier

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis on inoperable pancreatic cancer: a comparison between gemcitabine-based combination therapy and gemcitabine alone.

A new approach to managing intraductal papillary mucinous pancreatic neoplasms.

P2888

s00280-010-1299-8

P304

395-403

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-010-1299-8

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P50

Olivier Hermine

P577

2010-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42976274

http://www.w3.org/2001/XMLSchema#string

P6179

1030259579

http://www.w3.org/2001/XMLSchema#string

P698

20364428

http://www.w3.org/2001/XMLSchema#string